Evidence map›Paper›PMID 35754786›Full record

ArticleInfection and drug resistance2022

Mortality Risk Factors and Prognostic Analysis of Patients with Multi-Drug Resistant

Xinchun Wang, Qi Li, Jianbang Kang, Donghong Yin, Xiaoxia Li, Shuyun Wang, Qian Guo, Yan Song, Jing Wang, Jinju Duan

Abstract read
In one paragraph

Article in Infection and drug resistance, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Xinchun Wang *Department of Pharmacy, Second Hospital of Shanxi Medical University, Taiyuan, People's Republic of China.
Qi Li *Department of Pharmacy, Shanxi Medical University, Taiyuan, People's Republic of China.
Jianbang KangDepartment of Pharmacy, Second Hospital of Shanxi Medical University, Taiyuan, People's Republic of China.
Donghong YinDepartment of Pharmacy, Second Hospital of Shanxi Medical University, Taiyuan, People's Republic of China.
Xiaoxia LiDepartment of Pharmacy, Second Hospital of Shanxi Medical University, Taiyuan, People's Republic of China.
Shuyun WangDepartment of Pharmacy, Second Hospital of Shanxi Medical University, Taiyuan, People's Republic of China.
Qian GuoDepartment of Pharmacy, Second Hospital of Shanxi Medical University, Taiyuan, People's Republic of China.
Yan SongDepartment of Pharmacy, Second Hospital of Shanxi Medical University, Taiyuan, People's Republic of China.
Jing WangDepartment of Pharmacy, Second Hospital of Shanxi Medical University, Taiyuan, People's Republic of China.
Jinju DuanDepartment of Pharmacy, Second Hospital of Shanxi Medical University, Taiyuan, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The data from the China Network Antibacterial Surveillance Center (http://www.chinets.com) showed that the prevalence of Methods: 91 MDR strains from 91 patients were collected from 2015 to 2019 in the second hospital of Shanxi Medical University. The mortality risk factors for the MDRE infections and clinical outcomes were analyzed by univariable and multivariable analysis. The independent predictors of 30-day mortality were analyzed through the Cox regression analysis including the variables with a value <0.2. Results: The majority of patients were admitted to ICUs. Pulmonary infection was a major infection (43.96%, 40/91). Thirty-three (36.26%, 33/91) strains of MDR-KP were only detected in 2018. The proportion of multi-drug resistant Conclusion: This study implies that patients with cerebrovascular diseases, central venous catheterization, and endotracheal intubation are at risk of carrying MDR isolates.

Indexed as

carbapenem-resistantEnterobacteralesmulti-drug resistancerisk factors

Identifiers

PMID35754786
PMCPMC9231684

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.